Work

O-111 Docetaxel and COX-2 inhibition with celecoxib in progressive non-small cell lung cancer (NSCLC): Promising progression-free survival in a phase II study

Year: 2003

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(03)91769-7

Authors: Francis W. Nugent, Stephen Graziano, Rufus Collea, Nathan Levitan, Ajeet Gajra, John Freeman, Cathy O'Connell, Janine Marshall, Wilson Mertens, John McCann

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2074284538

Cites:

Cited by: 7

Related to: 10